NCT03734107

Brief Summary

Adolescents and young adults (AYAs; ages 17-23) with type 1 diabetes are at high risk for negative health outcomes, including poor glycemic control and disengagement from the health care system. The deterioration of glycemic control occurs in parallel with the assumption of independent self-care skills and preparation for adult diabetes care. Effective communication between AYAs and health care providers may be a critical contributor to diabetes self-care skills during the transition to adult diabetes care and related glycemic control. This research will attempt to better prepare adolescents and young adults for adult diabetes care by delivering innovative intervention content focused on both health communication skills and transition readiness skills. The investigators aim to leverage innovative technologies to improve developmentally-appropriate communication skills related to planning for clinic visits, disclosing and discussing diabetes-related concerns, and optimizing glucose data review in preparation for adult diabetes care. Adolescents and young adults with type 1 diabetes (ages 17-23) who are planning to transition to adult diabetes care within the next 6-8 months will be enrolled in the study and randomized to either the intervention group or a standard care control group. Medical, communication and psychosocial data (including A1c, glucose monitoring frequency, communication quality, health care engagement, depressive symptoms) will be collected from adolescent and young adult participants and health care providers at baseline and two follow-up time points, approximately 4 months post-baseline and approximately 8-12 months post-baseline after the transfer to adult diabetes care. This intervention has the potential to improve diabetes self-care skills, including engagement with health care providers, and glycemic control in AYAs with type 1 diabetes during the vulnerable period of transfer to adult diabetes care. The results of this work will inform best practices for the transition to adult diabetes care and can be translated into clinical care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

November 6, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 7, 2018

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2026

Completed
4 months until next milestone

Results Posted

Study results publicly available

May 5, 2026

Completed
Last Updated

May 5, 2026

Status Verified

May 1, 2026

Enrollment Period

5.1 years

First QC Date

November 1, 2018

Results QC Date

February 19, 2026

Last Update Submit

May 1, 2026

Conditions

Keywords

transition to adult medical careadolescents and young adultshealth communicationadherencetype 1 diabetes

Outcome Measures

Primary Outcomes (4)

  • Hemoglobin A1c

    percentage of glycated hemoglobin (Hemoglobin A1c)

    8 months post-baseline

  • Number of Days to First Adult Diabetes Care Visit

    Number of days between the last visit in pediatric diabetes care and the first visit in adult diabetes care (reported as number of days).

    8 months post-baseline

  • Adherence to the Diabetes Care Regimen

    Participant report on the Diabetes Management Questionnaire (DMQ), a self-report measure of adherence to the diabetes care regimen. The DMQ consists of 20 items scored on a 0-4 Likert Scale. The measure has a total score; the mean score on all items is calculated and multiplied by 25 to arrive at the total score (possible range 0-100). A higher score indicates greater adherence to diabetes management.

    8 months post-baseline

  • Diabetes-related Hospitalizations

    Participant report and medical record review of reported diabetes-related hospitalizations for the duration of the study period. The total number of diabetes-related emergency department visits/hospitalizations is summed.

    8 months post-baseline

Study Arms (2)

PREP-DC Intervention

EXPERIMENTAL

50 participants will be randomized to the Plan, Reflect, and Engage with Providers for Diabetes Care (PREP-DC) intervention. Participants will complete 3 intervention sessions with study interventionists and will receive text messages and other study resources during the active intervention period (3 months).

Behavioral: Plan, Reflect, and Engage with Providers for Diabetes Care

Standard Care Comparison

NO INTERVENTION

50 participants will be randomized to standard care and will participate in regular diabetes clinic visits and receive standard materials on the transition to adult diabetes care, as they would have done without participation in this study.

Interventions

Behavioral intervention designed to improve health communication skills and readiness for adult diabetes care

Also known as: PREP-DC
PREP-DC Intervention

Eligibility Criteria

Age17 Years - 23 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosed with type1 diabetes for ≥ 1 year
  • Able to adequately understand, speak, and read English to benefit from participation
  • Ready and consistent text messaging access to participate
  • Within 6-8 months of planned transfer to adult diabetes care

You may not qualify if:

  • Other life-threatening disease (e.g. cancer) or major psychiatric disorder (e.g. schizophrenia) that significantly limits participation
  • Pervasive developmental disorder that significantly limits participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's National Health System

Washington D.C., District of Columbia, 20010, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Limitations and Caveats

A total of 52 participants were enrolled in the trial (planned enrollment: 100 participants). This trial was impacted by the COVID-19 pandemic.

Results Point of Contact

Title
Dr. Randi Streisand
Organization
Children's National

Study Officials

  • Randi Streisand, PhD

    Children's National Research Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized in a 1:1 ratio to the intervention group or standard care comparison group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 1, 2018

First Posted

November 7, 2018

Study Start

November 6, 2018

Primary Completion

December 1, 2023

Study Completion

January 2, 2026

Last Updated

May 5, 2026

Results First Posted

May 5, 2026

Record last verified: 2026-05

Locations